BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2016

Nov 23, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2016-10-07

Reporting Person: Davis George Eric (EVP, General Counsel)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-10-07	Common Stock	G	360	—	Disposed	70798	Direct
2016-11-18	Common Stock	M	5000	$38.59	Acquired	75798	Direct
2016-11-18	Common Stock	S	5000	$90.42	Disposed	70798	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-11-18	Stock Option (Right to buy) Common Stock	$38.59	M	5000	Disposed	2018-05-21	Common Stock (5000)	Direct

Footnotes

F1: On October 7, 2016, the reporting person gifted 360 shares to an educational institution.

F2: Transaction made pursuant to a 10b5-1 trading plan executed on November 2, 2016.

F3: All shares were sold at the same price.

F4: Reflects the number of stock options outstanding after the transaction from this specific stock option grant.